Literature DB >> 22015396

Androgens and breast cancer.

Joanne Kotsopoulos1, Steven A Narod.   

Abstract

The role of androgens on breast cancer development and progression has not been fully elucidated. Several in vivo and in vitro studies demonstrate that androgens have an inhibitory effect on the mammary epithelium, whereas the majority of epidemiological studies report a positive association between high androgen levels and risk of breast cancer. Expression of the androgen receptor is a positive prognostic factor. Understanding the role of androgens in breast carcinogenesis is important because many women use testosterone replacement for the alleviation of symptoms brought on by menopause, in particular high-risk women who undergo surgical menopause at an early age. We overview the literature examining a role of androgens in the etiology of breast cancer.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22015396     DOI: 10.1016/j.steroids.2011.10.002

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  19 in total

1.  Endocrine disruptors fludioxonil and fenhexamid stimulate miR-21 expression in breast cancer cells.

Authors:  Yun Teng; Tissa T Manavalan; Chuan Hu; Svjetlana Medjakovic; Alois Jungbauer; Carolyn M Klinge
Journal:  Toxicol Sci       Date:  2012-10-10       Impact factor: 4.849

2.  Dietary lignan intake and androgen receptor expression in breast tumors.

Authors:  AnnaLynn M Williams; Matthew Bonner; Heather M Ochs-Balcom; Helena Hwang; Carl Morrison; Susan E McCann
Journal:  Cancer Causes Control       Date:  2014-12-04       Impact factor: 2.506

Review 3.  The importance of androgen receptors in breast cancer.

Authors:  Irina Niţă; Cornelia Niţipir; Ştefania Andreea Toma; Alexandra Maria Limbău; Edvina Pîrvu; Ioana Anca Bădărău
Journal:  Med Pharm Rep       Date:  2021-07-29

Review 4.  The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer.

Authors:  Utpalendu Paul; Satarupa Banerjee
Journal:  Mol Biol Rep       Date:  2022-03-02       Impact factor: 2.742

5.  Expression of androgen receptor and its phosphorylated forms in breast cancer progression.

Authors:  Qinghu Ren; Liying Zhang; Rachel Ruoff; Susan Ha; Jinhua Wang; Shilpa Jain; Victor Reuter; William Gerald; Dilip D Giri; Jonathan Melamed; Michael J Garabedian; Peng Lee; Susan K Logan
Journal:  Cancer       Date:  2013-04-19       Impact factor: 6.860

6.  L1CAM is expressed in triple-negative breast cancers and is inversely correlated with androgen receptor.

Authors:  Kai Doberstein; Karin Milde-Langosch; Niko P Bretz; Uwe Schirmer; Ayelet Harari; Isabell Witzel; Alon Ben-Arie; Michael Hubalek; Elisabeth Müller-Holzner; Susanne Reinold; Alain G Zeimet; Peter Altevogt; Mina Fogel
Journal:  BMC Cancer       Date:  2014-12-15       Impact factor: 4.430

7.  Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options.

Authors:  Pierluigi Gasparini; Matteo Fassan; Luciano Cascione; Gulnur Guler; Serdar Balci; Cigdem Irkkan; Carolyn Paisie; Francesca Lovat; Carl Morrison; Jianying Zhang; Aldo Scarpa; Carlo M Croce; Charles L Shapiro; Kay Huebner
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

8.  Evaluation of A-ring fused pyridine d-modified androstane derivatives for antiproliferative and aldo-keto reductase 1C3 inhibitory activity.

Authors:  Marina P Savić; Jovana J Ajduković; Jovana J Plavša; Sofija S Bekić; Andjelka S Ćelić; Olivera R Klisurić; Dimitar S Jakimov; Edward T Petri; Evgenija A Djurendić
Journal:  Medchemcomm       Date:  2018-04-30       Impact factor: 3.597

Review 9.  Expression and function of nuclear receptor co-activator 4: evidence of a potential role independent of co-activator activity.

Authors:  Alexandra Kollara; Theodore J Brown
Journal:  Cell Mol Life Sci       Date:  2012-05-05       Impact factor: 9.261

10.  Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.

Authors:  Renée T Fortner; A Heather Eliassen; Donna Spiegelman; Walter C Willett; Robert L Barbieri; Susan E Hankinson
Journal:  Breast Cancer Res       Date:  2013-03-06       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.